Literature DB >> 21822445

Activation of Latent TGF-β1 by Thrombospondin-1 is a Major Component of Wound Repair.

Jacques E Nör1, Luisa Dipietro, Joanne E Murphy-Ullrich, Richard O Hynes, Jack Lawler, Peter J Polverini.   

Abstract

PURPOSE: Thrombospondin 1 (TSP1) is a matrix glycoprotein that regulates cell adhesion, migration, and proliferation, and is a natural inhibitor of angiogenesis. Recent evidence suggests that TSP1 is a major physiologic activator of latent transforming growth factor-β1 (TGF-β1), and that TGF-β1 is important for wound healing. The purpose of this study was to examine whether excisional wound healing in TSP1-deficient mice is compromised as a result of deficient TGF-β1 activation.
MATERIALS AND METHODS: Punch wounds were made on the dorsum of TSP1 deficient and wild-type mice and the area of granulation tissue, number of microvessels, and inflammatory cell infiltration was evaluated over a period of 28 days.
RESULTS: TSP1 deficient mice showed impaired wound healing with persistent granulation tissue, decreased collagen content over time, and delayed arrival of macrophages compared to wild-type littermates. The number of microvessels in wounds of TSP1-deficient mice was approximately two-fold greater than in wild-type littermates 10 days after injury. Topical application of TSP1, or KRFK (a peptide derived from TSP1 that activates latent TGF-β1), to wounds of TSP1-deficient mice rescued wild-type patterns of wound repair and partially recovered local levels of TGF-β1 expression. Topical application of anti-TGF-β neutralizing antibody impaired the ability of KRFK to rescue normal patterns of wound neovascularization in TSP1-deficient mice.
CONCLUSIONS: These results demonstrate that TSP1 plays a key role in the orchestration of wound healing, and that TSP1-mediated activation of local TGF-β1 is an important step in this process.

Entities:  

Year:  2005        PMID: 21822445      PMCID: PMC3150167     

Source DB:  PubMed          Journal:  Oral Biosci Med        ISSN: 1742-3287


  41 in total

1.  Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells.

Authors:  N Guo; H C Krutzsch; J K Inman; D D Roberts
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

Review 2.  Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin.

Authors:  E H Sage; P Bornstein
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

3.  Thrombospondin-1 and its CSVTCG-specific receptor in wound healing and cancer.

Authors:  J J Roth; D Albo; V L Rothman; M T Longaker; M S Granick; C D Long; M P Solomon; G P Tuszynski
Journal:  Ann Plast Surg       Date:  1998-05       Impact factor: 1.539

4.  Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway.

Authors:  J E Nör; R S Mitra; M M Sutorik; D J Mooney; V P Castle; P J Polverini
Journal:  J Vasc Res       Date:  2000 May-Jun       Impact factor: 1.934

5.  Characterization of a macrophage-based system for studying the activation of latent TGF-beta.

Authors:  A Gosiewska; C F Yi; O Blanc-Brude; J C Geesin
Journal:  Methods Cell Sci       Date:  1999

Review 6.  The structural and functional properties of thrombospondin.

Authors:  J Lawler
Journal:  Blood       Date:  1986-05       Impact factor: 22.113

7.  The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.

Authors:  S Schultz-Cherry; J Lawler; J E Murphy-Ullrich
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

8.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

9.  Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1.

Authors:  P Bornstein
Journal:  J Cell Biol       Date:  1995-08       Impact factor: 10.539

10.  CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells.

Authors:  D W Dawson; S F Pearce; R Zhong; R L Silverstein; W A Frazier; N P Bouck
Journal:  J Cell Biol       Date:  1997-08-11       Impact factor: 10.539

View more
  14 in total

1.  The calreticulin-binding sequence of thrombospondin 1 regulates collagen expression and organization during tissue remodeling.

Authors:  Mariya T Sweetwyne; Manuel A Pallero; Ailing Lu; Lauren Van Duyn Graham; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

Review 2.  Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms.

Authors:  Mariya T Sweetwyne; Joanne E Murphy-Ullrich
Journal:  Matrix Biol       Date:  2012-01-14       Impact factor: 11.583

3.  Polymorphism in THBS1 gene is associated with post-refractive surgery chronic ocular surface inflammation.

Authors:  Laura Contreras-Ruiz; Denise S Ryan; Rose K Sia; Kraig S Bower; Darlene A Dartt; Sharmila Masli
Journal:  Ophthalmology       Date:  2014-03-27       Impact factor: 12.079

4.  Transforming growth factor-β in stem cells and tissue homeostasis.

Authors:  Xin Xu; Liwei Zheng; Quan Yuan; Gehua Zhen; Janet L Crane; Xuedong Zhou; Xu Cao
Journal:  Bone Res       Date:  2018-01-31       Impact factor: 13.567

Review 5.  Divergent modulation of normal and neoplastic stem cells by thrombospondin-1 and CD47 signaling.

Authors:  Sukhbir Kaur; David D Roberts
Journal:  Int J Biochem Cell Biol       Date:  2016-05-06       Impact factor: 5.085

6.  Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy.

Authors:  Ailing Lu; Mi Miao; Trenton R Schoeb; Anupam Agarwal; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

Review 7.  The matricellular protein thrombospondin-1 in lung inflammation and injury.

Authors:  Mohammadreza Tabary; Atish Gheware; Hernán F Peñaloza; Janet S Lee
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-01       Impact factor: 5.282

8.  Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis.

Authors:  Manuel A Pallero; Carrie A Elzie; Jiping Chen; Deane F Mosher; Joanne E Murphy-Ullrich
Journal:  FASEB J       Date:  2008-07-24       Impact factor: 5.191

Review 9.  Transforming Growth Factor Beta Signaling in Cutaneous Wound Healing: Lessons Learned from Animal Studies.

Authors:  Kenneth W Finnson; Praveen R Arany; Anie Philip
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-06       Impact factor: 4.730

10.  Growth Hormone-Releasing Peptide 6 Enhances the Healing Process and Improves the Esthetic Outcome of the Wounds.

Authors:  Yssel Mendoza Marí; Maday Fernández Mayola; Ana Aguilera Barreto; Ariana García Ojalvo; Yilian Bermúdez Alvarez; Ana Janet Mir Benítez; Jorge Berlanga Acosta
Journal:  Plast Surg Int       Date:  2016-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.